gliomatosis

简明释义

英[ˌɡlaɪəˈmoʊtəˌsɪs]美[ˌɡlaɪəˈmoʊtəˌsɪs]

n. 神经胶质过多

复 数 g l i o m a t o s e s

英英释义

单词用法

同义词

反义词

例句

1.Objective to characterize the diagnosis and treatment of gliomatosis cerebri (GC).

目的探讨脑胶质瘤病(GC)的诊断和治疗。

2.Objective To investigate the role of MRI in diagnosing gliomatosis cerebri (GC) and in stereotactic biopsy.

目的评价MRI在大脑胶质瘤病（GC）的诊断和立体定位活检中的价值。

3.Objective To investigate the role of MRI in diagnosing gliomatosis cerebri (GC) and in stereotactic biopsy.

目的评价MRI在大脑胶质瘤病（GC）的诊断和立体定位活检中的价值。

4.Objective to study the clinical, image and pathological features of cerebral gliomatosis.

目的研究大脑胶质瘤病的临床、影像学和病理学的特征。

5.The patient was diagnosed with gliomatosis, a condition characterized by the presence of multiple gliomas in the brain.

患者被诊断为神经胶质瘤病，这是一种特征是大脑中存在多个神经胶质瘤的疾病。

6.Treatment options for gliomatosis often include surgery, radiation, and chemotherapy.

对于神经胶质瘤病的治疗选择通常包括手术、放疗和化疗。

7.Doctors are studying how gliomatosis affects cognitive function over time.

医生们正在研究神经胶质瘤病如何随时间影响认知功能。

8.Symptoms of gliomatosis can vary widely depending on the location of the tumors.

根据肿瘤的位置，神经胶质瘤病的症状可能会有很大差异。

9.Research is ongoing to understand the genetic mutations associated with gliomatosis.

研究正在进行中，以了解与神经胶质瘤病相关的基因突变。

作文

Gliomatosis is a term that refers to a condition characterized by the presence of multiple gliomas in the brain or spinal cord. Gliomas are a type of tumor that arises from glial cells, which are supportive cells in the central nervous system. The term 'gliomatosis' encompasses a variety of glioma types, including astrocytomas, oligodendrogliomas, and ependymomas. Understanding this condition is crucial for both medical professionals and patients affected by it. In recent years, advancements in medical imaging and research have shed light on the complexities of gliomatosis. One of the most significant challenges faced by clinicians is the diagnosis of this condition. Symptoms can vary widely depending on the location and size of the tumors. Common symptoms include headaches, seizures, cognitive changes, and neurological deficits. Unfortunately, these symptoms can often be mistaken for other conditions, leading to delays in diagnosis and treatment. The treatment of gliomatosis (神经胶质瘤病) typically involves a multidisciplinary approach. Surgery may be necessary to remove accessible tumors, while radiation therapy and chemotherapy are often employed to manage the disease and prevent further tumor growth. However, the prognosis for patients with gliomatosis can be quite variable. Factors such as the specific type of glioma, the patient's age, and overall health play a significant role in determining outcomes. Research into the underlying mechanisms of gliomatosis is ongoing, with scientists exploring genetic mutations and environmental factors that may contribute to the development of these tumors. Additionally, clinical trials are being conducted to evaluate new treatment options, including targeted therapies and immunotherapy. These innovative approaches hold promise for improving the quality of life and survival rates for patients diagnosed with gliomatosis. For patients and their families, receiving a diagnosis of gliomatosis can be overwhelming. It is essential to seek support from healthcare providers, counselors, and support groups. Education about the condition is vital, as understanding the nature of gliomatosis can help patients make informed decisions about their treatment options. Furthermore, engaging in open discussions with medical professionals can empower patients to advocate for themselves throughout their treatment journey. In conclusion, gliomatosis (神经胶质瘤病) is a complex condition that requires a comprehensive understanding of its implications for diagnosis, treatment, and patient care. Continued research and collaboration among healthcare providers, researchers, and patients will be essential in advancing our knowledge and improving outcomes for those affected by this challenging disease. As we move forward, it is crucial to remain hopeful and proactive in the fight against gliomatosis.

神经胶质瘤病是一个术语，指的是在大脑或脊髓中存在多发性神经胶质瘤的状况。神经胶质瘤是一种肿瘤，起源于胶质细胞，胶质细胞是中枢神经系统中的支持细胞。术语“神经胶质瘤病”涵盖了多种类型的神经胶质瘤，包括星形胶质瘤、少突胶质瘤和室管膜瘤。理解这种情况对于医疗专业人员和受其影响的患者至关重要。近年来，医学影像学和研究的进展揭示了神经胶质瘤病的复杂性。临床医生面临的最大挑战之一是该病的诊断。症状因肿瘤的位置和大小而异。常见症状包括头痛、癫痫发作、认知变化和神经功能缺损。不幸的是，这些症状往往会被误认为其他疾病，导致诊断和治疗的延迟。神经胶质瘤病的治疗通常涉及多学科的方法。手术可能是必要的，以去除可及的肿瘤，而放疗和化疗通常用于管理疾病并防止肿瘤进一步生长。然而，神经胶质瘤病患者的预后可能相当不同。特定类型的神经胶质瘤、患者的年龄和整体健康状况等因素在确定结果方面起着重要作用。对神经胶质瘤病潜在机制的研究正在进行中，科学家们正在探索可能导致这些肿瘤发展的基因突变和环境因素。此外，正在进行临床试验，以评估新的治疗选择，包括靶向疗法和免疫疗法。这些创新方法为改善神经胶质瘤病患者的生活质量和生存率提供了希望。对于患者及其家人而言，获得神经胶质瘤病的诊断可能令人感到不知所措。寻求医疗提供者、顾问和支持团体的支持至关重要。了解这种疾病是至关重要的，因为了解神经胶质瘤病的性质可以帮助患者做出有关治疗选择的明智决定。此外，与医疗专业人员进行开放讨论可以让患者在整个治疗过程中为自己发声。总之，神经胶质瘤病是一个复杂的状况，需要全面理解其对诊断、治疗和患者护理的影响。持续的研究和医疗提供者、研究人员和患者之间的合作将对推进我们对这种具有挑战性的疾病的知识和改善结果至关重要。随着我们向前发展，保持希望和积极应对神经胶质瘤病的斗争至关重要。